Cargando…

Inflammatory signaling in NASH driven by hepatocyte mitochondrial dysfunctions

Liver steatosis, inflammation, and variable degrees of fibrosis are the pathological manifestations of nonalcoholic steatohepatitis (NASH), an aggressive presentation of the most prevalent chronic liver disease in the Western world known as nonalcoholic fatty liver (NAFL). Mitochondrial hepatocyte d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Myint, Melissa, Oppedisano, Francesca, De Giorgi, Valeria, Kim, Byeong-Moo, Marincola, Francesco M., Alter, Harvey J., Nesci, Salvatore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605416/ https://www.ncbi.nlm.nih.gov/pubmed/37884933 http://dx.doi.org/10.1186/s12967-023-04627-0

Ejemplares similares

Mitochondrial Dysfunction in the Transition from NASH to HCC
por: Léveillé, Mélissa, et al.
Publicado: (2019)

The genetic background shapes the susceptibility to mitochondrial dysfunction and NASH progression
por: Benegiamo, Giorgia, et al.
Publicado: (2023)

Cellular senescence in hepatocytes contributes to metabolic disturbances in NASH
por: Bonnet, Laurianne, et al.
Publicado: (2022)

Inflammation, Mitochondria and Natural Compounds Together in the Circle of Trust
por: Nesci, Salvatore, et al.
Publicado: (2023)

Cell Metabolism Therapy by Small Natural Compounds
por: Nesci, Salvatore, et al.
Publicado: (2023)

Mitochondrial Transfer by Human Mesenchymal Stromal Cells Ameliorates Hepatocyte Lipid Load in a Mouse Model of NASH
por: Hsu, Mei-Ju, et al.
Publicado: (2020)

Deficiency of WTAP in hepatocytes induces lipoatrophy and non-alcoholic steatohepatitis (NASH)
por: Li, Xinzhi, et al.
Publicado: (2022)

Inflammatory processes involved in NASH-related hepatocellular carcinoma
por: Cannito, Stefania, et al.
Publicado: (2023)

Immune and inflammatory pathways in NASH
por: Ganz, Michal, et al.
Publicado: (2013)

Hepatocyte phosphatase DUSP22 mitigates NASH-HCC progression by targeting FAK
por: Ge, Chenxu, et al.
Publicado: (2022)

Enjoy your journey: the bergamot polyphenols from the tree to the cell metabolism
por: Nesci, Salvatore, et al.
Publicado: (2021)

Impaired Mitochondrial Bioenergetics under Pathological Conditions
por: Nesci, Salvatore, et al.
Publicado: (2022)

Nonalcoholic steatohepatitis (NASH) is associated with cardiac remodeling and dysfunction
por: Simon, Tracey G., et al.
Publicado: (2017)

Noninvasive Diagnosis of NAFLD and NASH
por: Piazzolla, Valeria Annarita, et al.
Publicado: (2020)

Heat Shock Protein 27 is down-regulated in Ballooned Hepatocytes of Patients with Nonalcoholic Steatohepatitis (NASH)
por: Sookoian, Silvia, et al.
Publicado: (2016)

Gender difference in NASH susceptibility: Roles of hepatocyte Ikkβ and Sult1e1
por: Matsushita, Noriko, et al.
Publicado: (2017)

sTREM2 is a plasma biomarker for human NASH and promotes hepatocyte lipid accumulation
por: Kothari, Vishal, et al.
Publicado: (2023)

Butyrate limits inflammatory macrophage niche in NASH
por: Sarkar, Ankita, et al.
Publicado: (2023)

Hepatocyte-Specific Deletion of HIF2α Prevents NASH-Related Liver Carcinogenesis by Decreasing Cancer Cell Proliferation
por: Foglia, Beatrice, et al.
Publicado: (2021)

The Pathogenesis of HCC Driven by NASH and the Preventive and Therapeutic Effects of Natural Products
por: Shao, Gaoxuan, et al.
Publicado: (2022)

Hepatocyte-specific IL11 cis-signaling drives lipotoxicity and underlies the transition from NAFLD to NASH
por: Dong, Jinrui, et al.
Publicado: (2021)

Metformin Actions on the Liver: Protection Mechanisms Emerging in Hepatocytes and Immune Cells against NASH-Related HCC
por: Zhang, Yueqi, et al.
Publicado: (2021)

Obeticholic acid treatment ameliorates the cardiac dysfunction in NASH mice
por: Liu, Szu-Yu, et al.
Publicado: (2022)

9-PAHSA Prevents Mitochondrial Dysfunction and Increases the Viability of Steatotic Hepatocytes
por: Schultz Moreira, Adriana R., et al.
Publicado: (2020)

The role of mitochondrial genomics in patients with non-alcoholic steatohepatitis (NASH)
por: Mehta, Rohini, et al.
Publicado: (2016)

NASH is an Inflammatory Disorder: Pathogenic, Prognostic and Therapeutic Implications
por: Farrell, Geoffrey C., et al.
Publicado: (2012)

Sensitive and early detection of mitochondrial dysfunction in the liver of NASH model mice by PET imaging with (18)F-BCPP-BF
por: Sakai, Toshihiro, et al.
Publicado: (2018)

A case of NASH with genetic predisposition successfully treated with an SGLT2 inhibitor: a possible involvement of mitochondrial dysfunction
por: Nakajima, Rikako, et al.
Publicado: (2022)

Cell Autophagy in NASH and NASH-Related Hepatocellular Carcinoma
por: Udoh, Utibe-Abasi S., et al.
Publicado: (2022)

Hepatocyte-Specific Loss of PPARγ Protects Mice From NASH and Increases the Therapeutic Effects of Rosiglitazone in the Liver
por: Lee, Samuel M., et al.
Publicado: (2021)

Diet-induced gut dysbiosis and inflammation: Key drivers of obesity-driven NASH
por: Kang, Gideon G., et al.
Publicado: (2022)

Comprehensive Transcriptome Profiling of NAFLD- and NASH-Induced Skeletal Muscle Dysfunction
por: Guo, Mingwei, et al.
Publicado: (2022)

Dysfunctional T Follicular Helper Cells Cause Intestinal and Hepatic Inflammation in NASH
por: Wang, Haiguang, et al.
Publicado: (2023)

Nash vek /
por: Nappelʹbaum, Moisei Solomonovich, 1869-1958
Publicado: (1984)

Nash manifolds
por: Shiota, Masahiro
Publicado: (1987)

Involvement of mitochondrial ATP-sensitive K(+ )channels in fentanyl-induced mitochondrial dysfunction of cultured human hepatocytes
por: Djafarzadeh, S, et al.
Publicado: (2013)

Remodeling of Mitochondrial Plasticity: The Key Switch from NAFLD/NASH to HCC
por: Longo, Miriam, et al.
Publicado: (2021)

Mechanistic Insights of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis: An Update on a Lasting Relationship
por: Candelise, Niccolò, et al.
Publicado: (2022)

Modeling NASH and NASH-Induced Hepatocellular Carcinoma: Faster and Better
por: Hirsova, Petra
Publicado: (2021)

Development of the Rabbit NASH Model Resembling Human NASH and Atherosclerosis
por: Hayashi, Momoko, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qe416g7a7ar5iq10o7uqmg97s8